全文获取类型
收费全文 | 326450篇 |
免费 | 12129篇 |
国内免费 | 1149篇 |
专业分类
耳鼻咽喉 | 4291篇 |
儿科学 | 11600篇 |
妇产科学 | 8851篇 |
基础医学 | 43745篇 |
口腔科学 | 11688篇 |
临床医学 | 26741篇 |
内科学 | 64398篇 |
皮肤病学 | 8092篇 |
神经病学 | 24759篇 |
特种医学 | 13675篇 |
外国民族医学 | 99篇 |
外科学 | 41629篇 |
综合类 | 1635篇 |
一般理论 | 61篇 |
预防医学 | 29158篇 |
眼科学 | 6686篇 |
药学 | 22862篇 |
2篇 | |
中国医学 | 750篇 |
肿瘤学 | 19006篇 |
出版年
2023年 | 1260篇 |
2022年 | 2370篇 |
2021年 | 4973篇 |
2020年 | 3093篇 |
2019年 | 4173篇 |
2018年 | 8134篇 |
2017年 | 7189篇 |
2016年 | 6983篇 |
2015年 | 8655篇 |
2014年 | 9570篇 |
2013年 | 10511篇 |
2012年 | 20504篇 |
2011年 | 16400篇 |
2010年 | 8506篇 |
2009年 | 8987篇 |
2008年 | 11239篇 |
2007年 | 11850篇 |
2006年 | 11371篇 |
2005年 | 18729篇 |
2004年 | 19470篇 |
2003年 | 14277篇 |
2002年 | 8989篇 |
2001年 | 5470篇 |
2000年 | 2752篇 |
1999年 | 6838篇 |
1998年 | 1502篇 |
1992年 | 7229篇 |
1991年 | 7363篇 |
1990年 | 7604篇 |
1989年 | 7180篇 |
1988年 | 6684篇 |
1987年 | 6422篇 |
1986年 | 6145篇 |
1985年 | 5394篇 |
1984年 | 3767篇 |
1983年 | 3080篇 |
1979年 | 3923篇 |
1978年 | 2457篇 |
1977年 | 1870篇 |
1976年 | 1629篇 |
1975年 | 2533篇 |
1974年 | 3170篇 |
1973年 | 2782篇 |
1972年 | 2805篇 |
1971年 | 2788篇 |
1970年 | 2586篇 |
1969年 | 2492篇 |
1968年 | 2257篇 |
1967年 | 2191篇 |
1966年 | 1916篇 |
排序方式: 共有10000条查询结果,搜索用时 453 毫秒
81.
Samira Marín-Romero Teresa Elías-Hernández María Isabel Asensio-Cruz Rocío Ortega-Rivera Raquel Morillo-Guerrero Javier Toral Emilio Montero Verónica Sánchez Elena Arellano José María Sánchez-Díaz Macarena Real-Domínguez Remedios Otero-Candelera Luis Jara-Palomares 《Archivos de bronconeumología》2019,55(12):619-626
IntroductionScales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months.MethodsThis was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration).ResultsOf 353 patients evaluated, 195 were analyzed, with an average age of 53.5 ± 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p <.05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p <.05).ConclusionsOur study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). 相似文献
82.
Growth Hormone Induces Recurrence of Infantile Hemangiomas After Apparent Involution: Evidence of Growth Hormone Receptors in Infantile Hemangioma
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Naikhoba C. O. Munabi B.A. Qian Kun Tan H.S. Maria C. Garzon M.D. Gerald G. Behr M.D. Carrie J. Shawber Ph.D. June K. Wu M.D. 《Pediatric dermatology》2015,32(4):539-543
Infantile hemangiomas (IHs) are the most common benign tumor of infancy, characterized by a natural history of early proliferation in the first months of life to eventual involution during childhood, often with residual fibrofatty tissue. Once involution has been achieved, IHs do not typically recur. We present two cases of exogenous growth hormone therapy resulting in the recurrence of IHs in late childhood, supported by radiological, immunohistochemical, in vitro, and in vivo evidence. 相似文献
83.
Miguel A. Sanz Pau Montesinos Haesook T. Kim Guillermo J. Ruiz-Argüelles María S. Undurraga María R. Uriarte Lem Martínez Rafael H. Jacomo Homero Gutiérrez-Aguirre Raul A. M. Melo Rosane Bittencourt Ricardo Pasquini Katia Pagnano Evandro M. Fagundes Edo Vellenga Alexandra Holowiecka Ana J. González-Huerta Pascual Fernández Javier De la Serna Salut Brunet Elena De Lisa José González-Campos José M. Ribera Isabel Krsnik Arnold Ganser Nancy Berliner Raul C. Ribeiro Francesco Lo-Coco Bob L?wenberg Eduardo M. Rego 《Annals of hematology》2015,94(8):1347-1356
84.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
85.
86.
87.
88.
89.
About 10% of patients with Lyme disease continue to experience musculoskeletal pain and cognitive dysfunction after recommended antibiotic treatment. This condition is called post-Lyme disease syndrome (PLDS) or post-treatment Lyme disease syndrome. These two terms are used interchangeably. The pathogenesis of PLDS has been controversial. The hypothesis that patients with PLDS may harbor hidden reservoirs of Borrelia burgdorferi after their initial antibiotic treatment is difficult to accept. The prospective, double-blind studies contradict this point of view. Also, recently published research applying xenodiagnosis to PLDS supports the opinion that PLDS most likely has an autoimmune background. Lengthy courses of antibiotics are not justified in patients with PLDS because of the lack of benefit, and they are fraught with hazards. Most patients with PLDS recover from persistent symptoms with time. However, it can take months before they feel completely well. 相似文献
90.
European Child & Adolescent Psychiatry - 相似文献